Recent Press Coverage
January 2012 Nikkei Biotech — Dr. Kubota’s essay published in the Nikkei Biotech.
December 2011 Nikkei Business — “Nikkei Business, Special Edition dated December 19, 2011”
Nikkei Business published in December 2011 its Special Edition supplement highlighting who they believe will be particularly important figures in 2012. Dr. Kubota is included as one of those figures.
November/December 2011 PharmaVOICE — “Social Media: The Time has Come to Run the Hurdles”
November/December 2011 PharmaVOICE — “What's Ahead for 2012”
October 2011 Nikkei Business — “Nikkei Business 100”
September 2011 PharmaVOICE — “Mentoring More Crucial Now Than Ever”
July 2011 PharmaVOICE — “100 of the Most Inspiring People”
04/15/11 Ophthalmology Times — “Dry AMD treatments promising”
03/01/11 Ophthalmology Times — “Investigative drugs may battle AMD”
11/30/10 Xconomy — “Biotech’s Back in Seattle”
10/22/10 SmartPlanet — “Entrepreneur with a vision to cure blindness”
October 2010 Genetic Engineering & Biotechnology News — “Otsuka Taps Acucela for U.S. Development of Glaucoma Therapy”
October 2010 Retina Today — “Human Visual Cycle Modulation for Dry AMD”
09/27/10 Xconomy — “Acucela, Strengthening Ties With Japan’s Otsuka, Gets Right to Develop New Glaucoma Drug”
09/27/10 Genetic Engineering & Biotechnology News — “Otsuka Taps Acucela for U.S. Development of Glaucoma Therapy”
September 2010 AMD Alliance International — “ Research Progress for Dry AMD Treatments”
June 2010 Retina Today — “Imaging and Pharmacologic Approaches in the Treatment of Geographic Atrophy in AMD”
March 2010 PharmaVOICE — “PHASE I: From Animals to First-in-Human Studies”
February 2010 Foundation Fighting BlindnessSM — "Promising Dry AMD Treatment Moves into Phase II Clinical Trial"
01/20/10 Xconomy — "Acucela Enters Fast-Growth Phase As Macular Degeneration Drug Advances to Key Trial" 12/10/09 OSNSupersite.com — “Gene therapy for glaucoma could have potential”
November/December 2009 Retinal Physician — "Preclinical and Phase 1 Drugs in Development for Dry AMD: An Overview"
November/December 2009 PharmaVOICE — "What's in Store for 2010"
November/December 2009 PharmaVOICE — "Reform, Consolidation and Good Citizenry"
November/December 2009 PharmaVOICE — "Addressing the Innovation Challenge"
November 2009 Seattle Business Magazine — "Top 25 Innovators & Entrepreneurs"
11/02/09 MIT Technology Review — "Molecular Sunglasses for Macular Degeneration"
September 2009 EyeNet Magazine — "Dry AMD: Under Attack on Four Fronts"
09/28/09 Chemical & Engineering News — "Gaining Focus: Small-molecule drugs to treat dry age-related macular degeneration are heading to the clinic"
August 2009 Japan External Trade Organization (JETRO) — Profile of Acucela
08/10/09 Xconomy “Universal Healthcare Can Save Money, But Innovation Is Key: My Experiences in Japan and the U.S.”
July/August 2009 Start-Up — “Acucela Inc. Pursuing new targets for treating blinding eye diseases”
06/25/09, Vol 2, No 25, SciBX — “Seeing CNV sooner”
03/10/09 King 5 News — "Pill holds promise for macular degeneration treatment"